Saijo Hiroshi, Hirohashi Yoshihiko, Torigoe Toshihiko, Horibe Ryota, Takaya Akari, Murai Aiko, Kubo Terufumi, Kajiwara Toshimitsu, Tanaka Tsutomu, Shionoya Yosuke, Yamamoto Eri, Maruyama Reo, Nakatsugawa Munehide, Kanaseki Takayuki, Tsukahara Tomohide, Tamura Yasuaki, Sasaki Yasushi, Tokino Takashi, Suzuki Hiromu, Kondo Toru, Takahashi Hiroki, Sato Noriyuki
Department of Pathology, Sapporo Medical University School of Medicine, Sapporo, 060-8556, Japan.
Department of Respiratory Medicine and Allergology, Sapporo Medical University School of Medicine, Sapporo, 060-8556, Japan.
Oncotarget. 2016 Aug 2;7(31):50043-50056. doi: 10.18632/oncotarget.10571.
Cancer stem-like cells (CSCs)/cancer-initiating cells (CICs) are reasonable targets for cancer therapy. However, recent studies have revealed that some non-CSCs/CICs have plastic ability and can dedifferentiate into CSCs/CICs. Therefore, an understanding of the molecular mechanisms that control the plasticity is essential to achieve CSC/CIC-targeting therapy. In this study, we analyzed the plasticity of lung cancer cells and found that lung non-CSCs/CICs can dedifferentiate into CSCs/CICs in accordance with the expression of stem cell transcription factor SOX2. SOX2 expression was induced by the transcription factor HOXA5. Oxidative stress repressed the expression of HDAC8 and then induced histone 3 acetylation and increased the expression of HOXA5 and SOX2. These findings indicate that lung cancer cells have plasticity under a condition of oxidative stress and that HOAX5 has a critical role in dedifferentiation.
癌症干细胞样细胞(CSCs)/癌症起始细胞(CICs)是癌症治疗的合理靶点。然而,最近的研究表明,一些非CSCs/CICs具有可塑性,能够去分化为CSCs/CICs。因此,了解控制这种可塑性的分子机制对于实现针对CSC/CIC的治疗至关重要。在本研究中,我们分析了肺癌细胞的可塑性,发现肺非CSCs/CICs可根据干细胞转录因子SOX2的表达去分化为CSCs/CICs。SOX2的表达由转录因子HOXA5诱导。氧化应激抑制HDAC8的表达,进而诱导组蛋白3乙酰化并增加HOXA5和SOX2的表达。这些发现表明肺癌细胞在氧化应激条件下具有可塑性,且HOAX5在去分化过程中起关键作用。